Lowering Cholesterol

Novartis, Leqvio, Lowering Cholesterol, European Society of Cardiology,atherosclerotic cardiovascular disease

Novartis Unveils Breakthrough Long-Term Data: Leqvio Sustains LDL-C Reduction Beyond Six Years in ESC 2023

Anika Sharma

In the world of medical innovation, where the quest to tame cardiovascular risk is a relentless endeavor, Novartis unfurls a ...